UnitedHealth's Margin Pressure Could Impact Earnings Growth

UnitedHealth's stock price has been steadily increasing over the past year, but some analysts are warning of potential margin pressure that could impact the company's earnings. The bull case for UnitedHealth is a 32.7% upside in value, with a fair value of $503.78, according to FinQL. This would put the stock at around $379.85 as of September 9th, 2026. However, the bear case suggests that the company's profitability has deteriorated sharply, from 6.0% in 2021 to 2.7% in 2025.

The recovery of margins is seen as crucial for UnitedHealth's earnings growth, and analysts are projecting an increase in EPS from $19.76 in FY2026 to $26.22 in FY2028. However, this depends on stabilizing medical costs and rebuilding OptumHealth margins. The company's recent execution has been strong, with Q2 2026 EPS reaching $6.38 versus $4.85 expected, a 31.55% surprise.

The bear case also highlights the potential for profitability damage due to rising Medicare Advantage utilization and OptumHealth margin weakness. Regulatory exposure is another concern, with policy changes, investigations, and reimbursement reforms potentially pressuring risk adjustment and operating flexibility.